Key Non-coding Variants in Three Neuroapoptosis and Neuroinflammation-Related LncRNAs Are Protectively Associated with Susceptibility to Parkinson’s Disease and Some of Its Clinical Features-Reference-Cited by-同舟云学术

Key Non-coding Variants in Three Neuroapoptosis and Neuroinflammation-Related LncRNAs Are Protectively Associated with Susceptibility to Parkinson’s Disease and Some of Its Clinical Features

Published:2023-11-09 Issue: Volume: Page:
ISSN:0893-7648
Container-title:Molecular Neurobiology
language:en
Short-container-title:Mol Neurobiol

Author:

Shadkam Roshanak,Saadat Payam,Azadmehr Abbas,Chehrazi Mohammad,Daraei Abdolreza^ORCID

Funder

Vice-Chancellor for Research, Babol University of Medical Sciences

Publisher

Springer Science and Business Media LLC

Subject

Neuroscience (miscellaneous),Cellular and Molecular Neuroscience,Neurology

Link

https://link.springer.com/content/pdf/10.1007/s12035-023-03708-x.pdf

Reference78 articles.

1. DeMaagd G, Philip A (2015) Parkinson’s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. P & T : A Peer-Review J Formulary Manag 40(8):504–532

2. Tysnes OB, Storstein A (2017) Epidemiology of Parkinson’s disease. J Neural Transm (Vienna, Austria : 1996) 124(8):901–905. https://doi.org/10.1007/s00702-017-1686-y

3. Müller-Nedebock AC, Dekker MCJ, Farrer MJ, Hattori N, Lim S-Y, Mellick GD, Rektorová I, Salama M et al (2023) Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s disease. npj Parkinsons Dis 9(1):110. https://doi.org/10.1038/s41531-023-00535-8

4. Emamzadeh FN, Surguchov A (2018) Parkinson’s disease: biomarkers, treatment, and risk factors. Front Neurosci 12:612. https://doi.org/10.3389/fnins.2018.00612

5. Joseph J, Eng King T (2020) Parkinson’s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psych 91(8):795. https://doi.org/10.1136/jnnp-2019-322338